Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Cash (2016 - 2025)

Historic Change in Cash for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $30.1 million.

  • AtriCure's Change in Cash rose 2374.07% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year decrease of 6475.46%. This contributed to the annual value of $38.4 million for FY2024, which is 4654.53% up from last year.
  • As of Q3 2025, AtriCure's Change in Cash stood at $30.1 million, which was up 2374.07% from $17.9 million recorded in Q2 2025.
  • AtriCure's Change in Cash's 5-year high stood at $43.4 million during Q1 2021, with a 5-year trough of -$27.7 million in Q3 2021.
  • In the last 5 years, AtriCure's Change in Cash had a median value of $3.8 million in 2021 and averaged $5.6 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 74665.77% in 2021, then plummeted by 30511.85% in 2024.
  • AtriCure's Change in Cash (Quarter) stood at $3.8 million in 2021, then surged by 146.18% to $9.3 million in 2022, then crashed by 59.98% to $3.7 million in 2023, then crashed by 305.12% to -$7.6 million in 2024, then skyrocketed by 494.92% to $30.1 million in 2025.
  • Its Change in Cash stands at $30.1 million for Q3 2025, versus $17.9 million for Q2 2025 and -$22.8 million for Q1 2025.